Why most oral insulin formulations do not reach clinical trials

Volume: 6, Issue: 8, Pages: 973 - 987
Published: Aug 1, 2015
Abstract
Oral insulin able to induce an efficient antihyperglycemic effect either to replace or complement diabetes mellitus therapy is the major goal of health providers, governments and diabetic patients. Oral therapy is associated not only with the desire to exclude needles from the daily routine of diabetic patient but also with the physiological provision of insulin they would get. Despite numerous efforts over the past few decades to develop...
Paper Details
Title
Why most oral insulin formulations do not reach clinical trials
Published Date
Aug 1, 2015
Volume
6
Issue
8
Pages
973 - 987
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.